Author

Dalia S. El‐Gamil

Observed names: Dalia S El-Gamil, Dalia S. El-Gamil, El-Gamil, Dalia S, El-Gamil, Dalia S.

Institution: Ahram Canadian University

Observed institutions: Ahram Canadian University, German University in Cairo

ORCID: 0000-0002-0512-6724

Observed ORCID: 0000-0002-0512-6724

OpenAlex ID: A5063540751

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives

2023 · Ahmed K. ElHady, Dalia S. El-Gamil, et al. · Pharmaceuticals · 74

PDF

An overview of cdc2‐like kinase 1 (Clk1) inhibitors and their therapeutic indications

2022 · Ahmed K. ElHady, Dalia S. El‐Gamil, et al. · Medicinal Research Reviews · 45

Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights

2024 · Dalia S. El‐Gamil, Mohamed Y. Zaky, et al. · Drug Development Research · 22

PDF

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N -(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies

2023 · Ahmed A. Al-Karmalawy, Dalia S. El-Gamil, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 19

PDF

Design of Novel β‐Carboline Derivatives with Pendant 5‐Bromothienyl and Their Evaluation as Phosphodiesterase‐5 Inhibitors

2013 · Dalia S. El‐Gamil, Nermin S. Ahmed, et al. · Archiv der Pharmazie · 19

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency

2021 · Ahmed K. ElHady, Dalia S. El-Gamil, et al. · Molecules · 11

PDF

Development of novel conformationally restricted selective Clk1/4 inhibitors through creating an intramolecular hydrogen bond involving an imide linker

2022 · Dalia S. El-Gamil, Ahmed K. ElHady, et al. · European Journal of Medicinal Chemistry · 10

Discovery of novel 5-methoxybenzothiophene hydrazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivity

2022 · Dalia S. El-Gamil, Ahmed K. ElHady, et al. · European Journal of Medicinal Chemistry · 9

Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluation

2025 · Noreen Hemida, Dalia S. El-Gamil, et al. · Bioorganic Chemistry · 6

Benzothiophene nucleus in target-directed anti-cancer drug discovery

2026 · Patrick M. Maximous, Michael Emad, et al. · European Journal of Medicinal Chemistry · 4

Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer

2025 · Aya Fathy, Amro Allam, et al. · RSC Medicinal Chemistry · 3

PDF

Discovery of 1,3-disubstituted prop-2-en-1-one derivatives as inhibitors of neutrophilic inflammation via modulation of MAPK and Akt pathways

2024 · Mohammad Abdel-Halim, Dalia S. El-Gamil, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 3

Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity

2024 · Yara A Abd El-Rahman, Po-Jen Chen, et al. · Future Medicinal Chemistry · 3

PDF

An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present)

2026 · Mennatallah Abdallah, Parthiena M. Keddis, et al. · Expert Opinion on Therapeutic Patents

An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present)

2026 · Mennatallah Abdallah, Parthiena M. Keddis, et al. · Figshare

Dual inhibition of neutrophil superoxide generation and elastase release via JNK, ERK and FAK pathways: blockade by methoxy-chalcone derivatives

2026 · Dalia S. El-Gamil, Mennatallah A. Hammam, et al. · RSC Advances

PDF

List of contributors

2026 · Ashraf H. Abadi, Abdelrahman M. Abdelfattah, et al. · Elsevier eBooks

Splicing kinases in neuronal health and neurodegeneration

2026 · Dalia S. El-Gamil, Michael Emad, et al. · Elsevier eBooks

Pharmacokinetic assessment and metabolic stability of a novel multi-targeted Clk/Dyrk inhibitor using a validated LC-MS/MS method: In vitro and in vivo insights

2025 · Maryam Soliman, Noha Mostafa, et al. · Journal of Chromatography B

ChemInform Abstract: Design of Novel β‐Carboline Derivatives with Pendant 5‐Bromothienyl and Their Evaluation as Phosphodiesterase‐5 Inhibitors.

2013 · Dalia S. El‐Gamil, Nermin S. Ahmed, et al. · ChemInform

Works count: 25

Citation count: 223

H-index: 8

I10-index: 7